Leukemia is a medical term for cancer of the blood cells. Acute Myeloid Leukemia, known as AML is the most common acute leukemia in adults. AML is rapidly lethal if untreated, but overall survival has improved for those under age 65 from just 8 months in the late 1970s to 46 months in 2014. We’ll have the opportunity to hear from Dr. Mark Levis. He’s a Professor of Oncology and Director of the Adult Leukemia Service at The Johns Hopkins University School of Medicine. He’ll explain how and why AML develops, what puts us at risk, and then delve into standard treatments as well as effective, new, and targeted therapies that are extending life.